KALA BIO, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $70.2M | $105.0M | $183.1M |
| FY2019 | $71.2M | $29.7M | $85.4M |
| FY2020 | $72.2M | $100.0M | $77.3M |
| FY2021 | $78.9M | $16.8M | $92.1M |
| FY2022 | $37.9M | $19.0M | $70.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $70.2M | $105.0M | $183.1M |
| FY2019 | $71.2M | $29.7M | $85.4M |
| FY2020 | $72.2M | $100.0M | $77.3M |
| FY2021 | $78.9M | $16.8M | $92.1M |
| FY2022 | $37.9M | $19.0M | $70.5M |